comparemela.com

Latest Breaking News On - Isleworth healthcare acquisition - Page 1 : comparemela.com

Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress

Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer

Isleworth Healthcare Acquisition Corp (NASDAQ:ISLE) Sees Significant Decrease in Short Interest

Isleworth Healthcare Acquisition Corp. (NASDAQ:ISLE – Get Rating) was the target of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 3,800 shares, a drop of 85.5% from the April 30th total of 26,200 shares. Based on an average daily trading volume, of 43,000 […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.